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Abstract
The mixed lineage leukemia (MLL) protein is an epigenetic transcriptional regulator that controls proliferative expansion of
immature hematopoietic progenitors, whose aberrant activation triggers leukemogenesis. A mature MLL protein is
produced by formation of an intra-molecular complex and proteolytic cleavage. However the biological significance of
these two post-transcriptional events remains unclear. To address their in vivo roles, mouse mutant alleles were created that
exclusively express either a variant protein incapable of intra-molecular interaction (designated de) or an uncleavable
mutant protein (designated uc). The de homozygous mice died during midgestation and manifested devastating failure in
embryonic development and reduced numbers of hematopoietic progenitors, whereas uc homozygous mice displayed no
apparent defects. Expression of MLL target genes was severely impaired in de homozygous fibroblasts but unaffected in uc
homozygous fibroblasts. These results unequivocally demonstrate that intra-molecular complex formation is a crucial
maturation step whereas proteolytic cleavage is dispensable for MLL-dependent gene activation and proliferation in vivo.
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Introduction
MLL (also known as MLL1, HRX and KMT2A) is an
epigenetic transcriptional regulator that serves essential roles in
embryonic and hematopoietic development. During embryogen-
esis, MLL maintains expression of Homeobox (HOX) genes to
confer cellular identities along the anterior-posterior body axis [1],
[2]. In the hematopoietic lineage, MLL regulates expression of a
subset of HOX genes [3], [4] that promotes self-renewal of
hematopoietic stem cells (HSCs) and expansion of immature
progenitor pools [5], [6]. Hence, Mll deficiency in mice causes
hematopoietic failure accompanied with insufficient expansion of
immature hematopoietic progenitors [3], [7], [8]. Furthermore,
MLL suppresses premature-senescence in both human and mouse
fibroblasts in part by maintaining HOX gene expression [8], [9],
[10]. Therefore loss of MLL function causes premature senes-
cence. Conversely, MLL gain-of-function mutations caused by
chromosomal translocations in hematopoietic cells result in
constitutive expression of HOX genes that aberrantly enhance
proliferation [11], [12] and suppress senescence to cause acute
leukemia [8], [10].
MLL is translated as a large precursor protein (430 kD) that
subsequently undergoes proteolytic processing into two fragments
(MLLN and MLLC) by the Taspase 1 endopeptidase [13], [14],
[15], which specifically cleaves sites that are evolutionally
conserved with MLL2 (also known as MLL4, HRX2 and
KMT2B) and Drosophila TRX. The respective MLLN and
MLLC fragments form a holocomplex by non-covalent intra-
molecular interaction [14], [15]. Although these MLL fragments
are susceptible to distinct degradation pathways [8], the MLLN/
MLLC holocomplex is stably expressed because intra-molecular
complex formation masks structures that would otherwise lead to
degradation. However, the biological significance of these
maturation processes in vivo remains unclear.
In the current study, the in vivo roles of intra-molecular
complex formation and proteolytic processing in MLL functions
were examined using knock-in mouse lines with targeted
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Generation of knock-in mice
Targeting vectors containing the mutations and the cassettes of
Neomycin resistance gene (neo) and Diphtheria toxin gene (DT)
(kindly provided by Dr. Takeshi Yagi) were constructed by PCR-
mediated mutagenesis and restriction enzyme digestion/ligation.
The targeting vector for the uc mutation was constructed in the
same manner as the previously published dC mutant allele [8]. ES
cells (CGR8.8) were transfected with the linearized targeting
vectors and screened for positive clones by PCR. Homologous
recombination was confirmed by LA-PCR (Takara Bio Inc., Otsu,
Japan) using primer pairs specific for both ends of the targeting
construct (primer sequences available upon request). Targeted ES
clones were transiently transfected with a Cre recombinase
expression vector (kindly provided by Dr. Takeshi Yagi) and
subsequently screened for clones with appropriate excision of the
neo cassette. Blastocyst injections were performed by the
Transgenic Research Facility of Stanford University. Knock-in
mouse lines were maintained by backcrossing onto a C57BL/6
genetic background. Genotyping of mice for the de allele was
performed by PCR using a primer set (59- tgaactggtgggaaagcaca-
gacatcctga -39 and 59-agagatggttcagcggttaagagctctgac-39) that
detected both the mutant allele (,500 bp) and the wild type
allele (800 bp). Genotyping of mice for the uc allele was performed
by PCR using a primer set (59-gttctgaagcacacattccacacc-39 and 59-
catcaaagcgaagggcaatcagtg-39) that detected both the mutant allele
(,310 bp) and the wild type allele (250 bp).
Cell culture
293T, plat-E, and mouse embryonic fibroblast (MEF) cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 15% fetal calf serum and non-essential amino
acids.
Western blotting
Western blotting was performed as described previously [15].
The mouse monoclonal anti-MLLN antibody (mmN4) and anti-
MLLC antibody (9–12) were previously described [8], [15]. Goat
anti-menin antiserum (C19) was purchased from Santa Cruz
Biotechnology Inc (Santa Cruz, CA) and mouse anti-actin
antibody (MAB 1501R) was purchased from Millipore (Billerica,
MA).
RT-PCR
Reverse transcription (RT) was performed as described
previously [8]. RT-PCR of the mouse de variant transcript was
performed using a primer set flanking the exon 11 counter part
sequences (59-agatggagtccacaggatca-39 and 59-tttcttcgtgggtttggtgg-
39). Quantitative PCR (qPCR) was performed in triplicate and
average expression levels (with standard deviations) normalized to
that of Gapdh or Actb were calculated using a standard curve and
the relative quantification method as described in ABI User




_g1, Cdkn2c:Mm00483243_m1, Hoxc4:Mm00442838_m1, Hoxc9:
Mm00433972_m1, PAI-1(Serpine1):Mm00435860_m1, Men1:Mm
00484963_m1, Ledgf (Psip1):Mm01259222_g1, Hoxa10:Mm00433
966_m1,Hoxa9:Mm00439364_m1,Hoxa7:Mm00657963_m1] were
purchased from Applied Biosystems (Foster City, CA).
Flow cytometry analysis and sorting
Flow cytometry was performed as previously described [8], [16].
Single cell suspensions harvested from the bone marrow and
thymus were stained in deficient RPMI (Irvine Scientific, Santa
Ana, CA) containing 3% fetal calf serum, 1 mM EDTA and
10 mM HEPES. Conjugated monoclonal antibodies (mAbs) were
obtained from either BD (Flanklin Lakes, NJ) or eBioscience (San
Diego, CA). The lineage cocktail included antibodies for Gr1
(RB6-8C5), B220 (RA3-6B2), TER119 (TER-119), CD3 (145-
2C12), CD4 (GK1.5), and CD8 (53-6.7). The following mAbs
were also used: Mac1/CD11b (M1/70), cKit (2B8), Sca1 (D7),
CD48 (HM48-1), CD34 (49E8), CD16/32 (93), Flk2 (A2F10),
CD45.2 (104), and CD43 (S7). Stained cells were analyzed with
LSR-1A or LSR-II flow cytometer (BD). J-SAN (Bay bioscience,
Kobe, JAPAN) was used for cell sorting. Cell Quest Pro or Diva
(BD) was used for data acquisition, and FlowJo (Tree Star Inc.,
Ashland, OR) was used for analysis.
In vivo reconstitution assay
Fetal liver cells of de homozygous mutant (56105 cells) or the
wild type/heterozygous controls (56104 cells) harvested from
E12.5 embryos or white blood cells harvested from adult uc
homozygous mice (16106 cells) or the wild type control (16106
cells) in the littermates were injected intravenously into lethally
irradiated (1200 rads in two days or 900 rads in one day) C57BL/
6 mice. Recipient mice were maintained on water supplemented
with antibiotics for a few weeks after transplantation.
Whole mount in situ hybridization
In situ hybridization was performed on E10.5 embryos as
described elsewhere [8], [17]. The Hoxc8 probe was synthesized
using DIG RNA labeling kit (Roche) and hybridized with pre-
treated embryos. After washing, the probe was visualized by anti-
Figure 1. Intra-molecular interaction is required for MLL-dependent gene activation. A. MLL proteins produced by dC and de mutations
are shown schematically. The characteristics of each mutant are shown on the right. The N-terminal intra-molecular interaction domain (NIID)
includes PHD1, PHD4 and FYRN and the C-terminal intra-molecular interaction domain (CIID) is FYRC. Positions of the three taqman probes for Mll
[Mll(N), Mll(M) and Mll(C)] used in Figure 1G are indicated by red bars. Genomic sequences around the exon 11 of the human MLL and its murine
counterpart are shown at the bottom. B. Genomic structures of the wild type allele and the recombined allele are shown with the targeting vector. C.
Diagnostic PCR identifies the recombined allele in genetically engineered mice. +/+: wild type. de/+: de heterozygous D. Sequence of the exon
junction of Mll de transcript. The PCR product generated by RT-PCR of de homozygous MEFs was sequenced. E. Genotypes at various developmental
stages. Viability of embryos was confirmed by presence of heart contractions. de/de: de homozygous F. Morphologies of E13.5 embryos of demutants.
G. Expression of MLL proteins and RNAs in MEFs. Expression of MLLN, MLLC, and actin was visualized by western blotting. Relative expression levels of
Mll mRNAs (normalized to Gapdh) are expressed relative to those of wild type arbitrarily set as 1. RT-PCR analysis demonstrated expression of the de
mutant mRNAs. qPCR using the Mll(M) and Mll(C) taqman probe demonstrated that Mll mRNAs were expressed at the same levels in wild type and de
homozygous MEFs, whereas the Mll(N) taqman probe showed that the murine exon corresponding to the human exon 11 was not transcribed. Error
bars represent the standard deviations of triplicate PCRs. H. Expression of MLL target genes in de homozygous MEFs. Wild type and dC homozygous
MEFs were also analyzed for comparison. Relative expression levels of various MLL target genes (normalized to Gapdh) are expressed relative to those
of wild type-1 arbitrarily set as 1. RT-qPCR demonstrates that expression of MLL target genes including Hoxc8, Hoxc9, Cdkn1b, Cdkn2c was impaired in
de homozygous and dC homozygous MEFs. Error bars represent the standard deviations of triplicate PCRs. dC/dC: dC homozygous.
doi:10.1371/journal.pone.0073649.g001
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digoxygenin antibody coupled with alkaline phosphatase. The
plasmid for the Hoxc8 probe was kindly provided by Dr. Licia
Selleri.
MEF proliferation and 3T3 senescence assays
MEFs were derived from E11.5 embryos and analyzed as
described elsewhere [8], [18]. The MEFs were plated at the
concentration of 104 cells/ml on Day 0 and the cell count was
Figure 2. Intra-molecular interaction is required for expansion of hematopoietic progenitors. A. Cellularity of de mutant FLs. Error bars
represent the standard deviations of cell numbers of FLs. For each genotype, at least 3 livers were analyzed. B. Population analysis of de mutant FLs by
flow cytometry. The fetal LKS compartment was defined as the Lin2cKit+Sca-1+Mac1+ population. C. Frequency of LKS populations in de mutant FLs.
Error bars represent the standard deviations of more than two littermate embryos for each genotype. D. Population analysis of HSCs from MPPs in
de mutant FLs by flow cytometry. Lin2Mac1+ cells were subdivided by Sca-1 and CD48. E. Frequencies of HSCs (top) and MPPs (bottom) in de mutant
FLs. Error bars represent the standard deviations of more than four embryos for each genotype. Frequency was expressed as the percentage of each
fraction within the whole population. F. Ability of de mutant FL cells to reconstitute the hematopoietic system. 56105 cells of de homozygous FLs and
56104 cells of the wild type/heterozygous controls were transplanted into lethally irradiated syngenic mice. Previously published data for
dC homozygous FLs [8] obtained in the same experimental setting were included for comparison. N: the number of FLs analyzed.
doi:10.1371/journal.pone.0073649.g002
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Figure 3. MLL processing is not required for MLL-dependent gene activation. A. Schematic structures of MLL proteins produced by dC and
uc mutations. The characteristics of each mutant are shown on the right. The mutated processing sites are highlighted in red. B. Sequences at the
processing sites of the PCR fragments amplified from genomic DNAs of the recombined ES cell clones. C. Expression of MLL proteins in embryos.
Western blotting was performed on whole embryo extracts of various genotypes. MLL proteins were visualized by anti-MLLC antibody. Anti-menin
blot serves as a loading control. uc/+: uc heterozygous. uc/uc: uc homozygous. dC/+: dC heterozygous. dC/ dC: dC homozygous. D. Genotypes at
various developmental stages. Viability of embryos was confirmed by presence of heart contractions. E. Expression of Hoxc8 transcripts in E10.5
embryos. Whole mount in situ hybridization was performed using the Hoxc8 probe (Hoxc8). Arrows indicate sites of target gene expression.
Previously published data for the wild type and dC homozygous embryos [8] are shown here for comparison. F. Expression of various genes in mutant
MEFs. Three independently established MEF lines of wild type, uc homozygous and dC homozygous genotypes were examined by RT-qPCR for genes
indicated at the tops of respective panels. Relative expression levels (normalized to Gapdh) are expressed relative to those of wild type-1 arbitrarily
set as 1. Previously published data for wild type and dC homozygous MEFs [8] obtained in the same experiment are included for comparison. Error
bars represent the standard deviations of triplicate PCRs. G. Proliferative capacities of uc homozygous MEFs. Proliferation assay (top) and 3T3
senescence assay (bottom) were performed for three lines each of wild type, uc homozygous and dC homozygous genotypes at passage 3. Previously
published data for wild type and dC homozygous MEFs [8] obtained in the same experiments are included for comparison.
doi:10.1371/journal.pone.0073649.g003
Figure 4. Processing of MLL is not required for adult hematopoiesis. A. Population analysis of Lin2cKit+Sca12 (MP) and Lin2cKit+Sca1+ (LKS)
compartments and their subcompartments in the BM of adult uc mutant mice. Lineage cocktail (anti-CD3, CD4, CD8, B220, TER119, Gr-1, Mac1/
CD11b) was used to define lineage negative fractions. B. Frequencies of hematopoietic progenitors (Flk22MPP, Flk2+MPP, CMP, GMP and MEP) and
HSCs in uc mutant mice. Error bar represents standard deviations of three independent samples.
doi:10.1371/journal.pone.0073649.g004
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measured at each time point. In 3T3 senescence assay, the MEFs
were re-plated every 3 days.
Myeloid progenitor serial replating assay
Myeloid progenitor serial replating assay was described
elsewhere [19], [20]. Myeloid progenitor cells were harvested
from the femurs of mice. C-kit positive cells were enriched by
immuno-magnetic selection using an Auto MACS (Miltenyi
Biotech), transduced with recombinant retrovirus by spinocula-
tion, and plated in methylcellulose medium (M3231, Stemcell
Technologies) containing SCF, IL-3, IL-6 and GM-CSF. The
colony-forming units (CFUs) per 104 plated cells were quantified
after 5–7 d of culture and expressed as the average and standard
deviation of at least triplicate determinations.
Results
Intra-molecular complex formation of MLL fragments is
essential for MLL-dependent gene activation
The intra-molecular interaction domains of MLL have been
defined as PHD fingers 1 and 4 (PHD1 and PHD4), FYRN, and
FYRC domains [8], [15] (Figure 1A). Most of PHD1 is encoded by
exon 11 of MLL. It has been reported that an MLL variant
protein lacking exon 11 sequences is dominantly expressed in some
cases of acute lymphoid leukemia [21]. We previously reported
that this variant protein can be transiently expressed and efficiently
processed but is incapable of forming an MLLN/ MLLC
holocomplex [8]. To investigate the in vivo roles of intra-
molecular complex formation, a mutant allele (designated de) that
lacks the exon 11 counterpart of mouse was generated in ES cells
(Figure 1B) and its successful recombination was confirmed by
diagnostic genomic PCR (Figure 1C) and RT-PCR followed by
sequencing (Figure 1D). Another mutant allele (designated dC),
which served as a control for null mutation, was previously
engineered to contain a stop codon at the second processing site
[8], thereby exclusively expressing MLLN due to the inability to
translate downstream MLLC sequences within the Mll mRNA
(Figure 1A).
Unlike wild type and de heterozygous mice, de homozygous mice
died during midgestation (Figure 1E) with a similar phenotype
displayed by dC homozygous (dC/dC) mice [8], including
subcutaneous edema and hemorrhage (Figure 1F). Mouse
embryonic fibroblasts (MEFs) derived from de homozygous
embryos expressed MLL proteins at low or undetectable levels
whereas their respective mRNAs were expressed at normal levels
(Figure 1G), confirming previous findings that MLL protein
fragments are subjected to degradation if unable to self-associate in
an intra-molecular complex [8], [14]. Consequently, expression of
MLL target genes including Hoxc8, Hoxc9, Cdkn1b and Cdkn2c was
severely reduced in de homozygous MEFs [22], [23] (Figure 1H).
These results clearly demonstrate that intra-molecular complex
formation is required for stable expression of MLL proteins and
thus for MLL-dependent gene activation in vivo.
Intra-molecular complex formation is required for
expansion of hematopoietic progenitors
The effect of intra-molecular complex formation on prolifera-
tive expansion of hematopoietic progenitors was examined by flow
cytometry analysis of the fetal livers (FLs) derived from de
homozygous E12.5 embryos, which contained fewer hematopoi-
etic cells compared to the wild type/heterozygous control FLs
(Figure 2A). The LKS compartment, which contains HSCs and
multi-potent progenitors (MPPs), was markedly reduced in de
homozygous FLs (Figure 2B, 2C). Further analysis using the CD48
marker [24] showed that de homozygous FLs produced HSCs 50%
less efficiently than the wild type/heterozygous controls (Figure 2D,
2E). MPP frequency was more profoundly affected by loss of intra-
molecular complex formation, phenocopying dC homozygous FLs
[8]. Transplantation of FL cells into lethally irradiated mice
showed that de homozygous FL cells were unable to reconstitute
Figure 5. Lack of processing does not constitutively activate
MLL. A. Expression of posterior Hoxa genes and MLL complex
components during myeloid differentiation. Each population was
isolated by cell sorting and analyzed by RT-qPCR. Relative expression
levels (normalized to Actb) and expressed relative to those of LKS
arbitrarily set as 100%. Error bars represent standard deviations of
triplicate PCRs. B. Experimental scheme of myeloid progenitor serial
replating assay. MLL-ENL was transduced into wild type myeloid
progenitors in Figure 5C. Colony-forming activity of wild type and uc
homozygous myeloid progenitors was analyzed without any gene
transduction in Figure 5D. C. Clonogenic potentials of MLL-ENL (or
vector)-transduced myeloid progenitors in myeloid progenitor serial
replating assay. Transduced cells were cultured in semi-solid media and
subjected to serial replating. CFUs per 104 plated cells were enumerated
after each round. Error bars represent standard deviations of three
independent samples. D. Clonogenic potentials of myeloid progenitors
derived from uc homozygous mice in myeloid progenitor serial
replating assay. Error bars represent standard deviations of three
independent samples.
doi:10.1371/journal.pone.0073649.g005
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the hematopoietic system, while a 10-fold lower cell number of the
wild type/heterozygous control FL cells successfully reconstituted
(Figure 2F). These results show that intra-molecular complex
formation is essential for the functions of MLL to generate
appropriate numbers of fetal HSCs and MPPs in vivo.
Proteolytic processing of MLL is not required for MLL-
dependent gene activation
To investigate the in vivo roles of proteolytic processing of
MLL, we generated a knock-in mouse line (designated uc) with
targeted germline mutations of the MLL processing sites. ES cells
were engineered to contain an alanine substitution mutation at the
critical aspartic acid residue in both processing sites (the murine
counterparts of human D2666 and D2718) [8], [10] thereby
expressing an uncleavable mutant of MLL (MLLuc) (Figure 3A).
Genomic PCR followed by sequencing confirmed that recombined
ES cells harbored the targeted allele (Figure 3B). Western blotting
analysis confirmed expression of MLLuc in uc mutant embryos
(Figure 3C). uc homozygous mice were born at normal Mendelian
ratios (Figure 3D) with no apparent anatomic/functional defects.
Hoxc8, an MLL target gene [2], was properly expressed in uc
homozygous embryos at E10.5, where dC homozygous embryos
failed to maintain its expression [8] (Figure 3E). Thus, an inability
to proteolytically process MLL does not compromise the
developmental roles of MLL.
To further investigate the possible effect of MLL processing on
MLL-dependent transcription, MEF cell lines of wild type, uc
homozygous and dC homozygous genotypes were analyzed by RT-
qPCR. In contrast to the comparable expression of Mll and Hoxc4
mRNAs among all the cell lines, expression of MLL target genes
including Hoxc8, Hoxc9, Cdkn2c and Cdkn1b [8], [22], [23] was
substantially reduced in dC homozygous MEFs but unaffected in uc
homozygous MEFs (Figure 3F). Although Taspase I knock-out
MEFs, which exclusively express the unprocessed form of MLL,
were reported to over-express Cdkn2a, uc homozygous MEFs
expressed Cdkn2a at comparable levels to the wild type control,
indicating that processing of MLL is not required for suppression
of Cdkn2a expression. Furthermore, in contrast to a report by
Takeda et al. [25], no severe growth retardation of uc homozygous
MEFs was observed in proliferation assays and in 3T3 senescence
assays, in the condition where dC homozygous MEFs displayed a
premature senescence phenotype [8] (Figure 3G). Consistent with
these results, PAI-1 (also known as Serpine-1), a well-known
senescence inducer [26], was highly expressed in dC homozygous
MEFs, but expressed at normal levels in uc homozygous MEFs.
Hence, processing of MLL is not required for MLL-dependent
transcription in contrast to the severe compromise of MLL
functions caused by the inability to self-associate.
Lack of MLL processing does not affect steady state
hematopoiesis
To investigate the role of MLL processing in hematopoiesis, we
analyzed the hematopoietic compartments of adult uc mutant mice
by flow cytometry (Figure 4A, 4B). HSCs, MPPs, and lineage-
restricted progenitors including common myeloid progenitors
(CMPs), granulocyte/monocyte progenitors (GMPs) and mega-
karyocyte/erythroid progenitors (MEPs) in bone marrow (BM)
exhibited normal frequencies. Furthermore, T-cells in thymus, and
B- cells in BM also exhibited normal compositions (data not
Figure 6. MLL processing is not required for proliferation of oncogene-transformed myeloid progenitors. A. Experimental scheme of
myeloid progenitor serial replating assay. Hoxa9 was transduced in Figure 6B and MLL-AF9 in Figure 6C and 6D. The time points at which colony
forming units and Hoxa9 expression were measured are shown. B. Clonogenic potentials of Hoxa9-transformed myeloid progenitors of wild type or uc
homozygous mutant origin. CFUs per 104 plated cells were enumerated at third and fourth round. Error bars represent standard deviations of three
independent samples. C. Clonogenic potentials of MLL-AF9-transformed myeloid progenitors of wild type or uc homozygous mutant origin. CFUs per
104 plated cells were enumerated at third and fourth round. Error bars represent standard deviations of three independent samples. D. Hoxa9
expression in the first round colonies of MLL-AF9-transformed cells. Relative expression levels (normalized to Gapdh) and expressed relative to those
of MLL-AF9-transformed wild type progenitors arbitrarily set as 100%. Error bars represent standard deviations of triplicate PCRs.
doi:10.1371/journal.pone.0073649.g006
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shown). Thus, MLL processing is dispensable for steady-state
hematopoiesis in adult mice.
The uncleavable mutant of MLL is not constitutively
active
MLL maintains HOX gene expression to promote expansion of
hematopoietic progenitors during myeloid differentiation [3], [4].
Because Hox gene expression progressively declines as cells
differentiate [12], [27] (Figure 5A, upper panel), the transcrip-
tional activity of MLL is presumed to decline in parallel.
Transcripts for essential components of the MLL complex (MLL
itself, menin and LEDGF) are also down-regulated as cells
differentiate (Figure 5A, lower panel). However, their declining
expression levels were not quantitatively in accord with those of
Hox genes. Noticeably, their expression levels in differentiated cells
(ckitlowMac1high) were similar to the levels present in MLL-ENL-
transformed cells, whose growth is critically dependent on menin
and LEDGF [28], [29], [30]. These data suggest that the decline
of Hox gene expression during differentiation is not entirely due to
the decrease of MLL complex components at the mRNA level;
rather, a post-transcriptional regulatory mechanism might mediate
down-regulation of MLL-dependent transcription. We hypothe-
sized that dissociation of the MLLC subunit may occur during
differentiation to extinguish MLL function, whereas uncleavable
MLL might function as the constitutively active form. In this
scenario, myeloid progenitors derived from uc homozygous mice
should exhibit enhanced clonogenicity in vitro similar to that
induced by MLL-ENL, which behaves as the constitutively active
form that aberrantly maintains Hoxa9 expression and promotes
proliferation (Figure 5B, 5C). However, uc homozygous myeloid
progenitors did not display enhanced replating activity compared
to the wild type control (Figure 5B, 5D). Thus, lack of processing
does not render MLL constitutively active in hematopoietic
progenitors.
MLL processing is not required for oncogene-dependent
proliferation of myeloid progenitors
To examine whether MLL processing is required for the
enhanced proliferation of hematopoietic progenitors induced by
oncogenes, we transduced myeloid progenitors derived from uc
homozygous mice with Hoxa9 expression vector and analyzed their
serial replating activity (Figure 6A). Despite the lack of processing,
Hoxa9-transformed uc homozygous myeloid progenitors exhibited
clonogenicity comparable to the wild type control (Figure 6B).
These results demonstrate that MLL processing is not required for
proliferation of oncogene-transformed myeloid progenitors.
Figure 7. MLL processing is not required for self-renewal of hematopoietic stem cells. A. Experimental scheme of serial reconstitution
assay. The time point at which the genotype of hematopoietic cells was examined is indicated. B. Survival of lethally irradiated mice transplanted with
BM cells derived from adult uc homozygous mice and their littermate wild type control. Mock control mice die two to three weeks after irradiation. C.
Genotype of reconstituted hematopoietic cells in the BM of recipient mice. The BM cells were prepared from femurs and subjected to genotyping
PCRs. D. Reconstitution potentials of the donor cells before eventual exhaustion of HSCs. Recipient mice that survived for 60 days after
transplantation were subjected to the next round of bone marrow transplantation (BMT). Average times of successful reconstitution were expressed
with error bars that represent standard deviations of nine independent samples. E. Model of MLL protein maturation.
doi:10.1371/journal.pone.0073649.g007
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It has been reported that the wild type MLL protein is required
for leukemic transformation by the MLL-AF9 oncogene [28]. This
notion presumes that the function of MLL must be preserved for
MLL-AF9 to activate Hoxa9 expression and transform myeloid
progenitors. MLL-AF9 successfully transformed uc homozygous
myeloid progenitors (Figure 6C) and activated Hoxa9 expression
(Figure 6D) in a serial replating assay (Figure 6A). Hence, the
uncleavable form of MLL is equivalently functional to the
processed form of MLL in MLL-AF9-transformed myeloid
progenitors.
MLL processing is not required for self-renewal of HSCs in
vivo
Previous studies have shown that MLL serves an important role
in self-renewal of HSCs and therefore is necessary to reconstitute
the hematopoietic system in vivo [3], [7], [8] (Figure 2F). To
examine the role of MLL processing in self-renewal, we performed
serial in vivo reconstitution assays using wild type and uc
homozygous donor cells derived from littermate mice
(Figure 7A). uc homozygous BM cells successfully reconstituted
the hematopoietic system as well as the wild type control
(Figure 7B, 7C). Serial reconstitution assays showed that uc
homozygous HSCs and the wild type control consecutively
reconstituted three times on average before the eventual depletion
of HSCs (Figure 7D), demonstrating that uc homozygous HSCs
retain equivalent reconstituting potentials to the wild type control.
These results indicate that MLL processing is not required for self-
renewal of HSCs in vivo.
Discussion
In this study, we generated mouse mutant alleles that effectively
inhibit intra-molecular complex formation and MLL processing,
respectively, to address the in vivo roles of these two maturation
steps. Loss of intra-molecular interaction had devastating effects
and manifested a null phenotype, demonstrating that intra-
molecular interaction of MLLN and MLLC is essential for MLL
functions. These results indicate that loss of intra-molecular
interaction exposes the FYRN domain, which triggers degradation
and leads to loss-of-function of MLL as we previously reported [8].
On the other hand, in spite of the evolutionary conservation of the
processing sites, loss of processing caused no measurable defects,
indicating that processing is mostly dispensable for MLL-
dependent functions. Furthermore, uc homozygous cells have
normal proliferation capacity, demonstrated by proliferation assay
of MEFs, serial replating assay of oncogene-transformed hemato-
poietic progenitors, and serial in vivo reconstitution assay.
Therefore, our results do not support the previously suggested
essential role of MLL processing in cell cycle progression. Taken
together, MLL processing is not required for its function unlike
many other bioactive peptides that become activated by proteo-
lytic cleavage, whereas intra-molecular complex formation is an
essential step in MLL maturation. Because cleavage occurs to the
MLL mutant proteins that are incapable of intra-molecular
interaction, the intra-molecular interaction itself is not a prereq-
uisite for Taspase 1-dependent cleavage [8]. However, if cleavage
occurs before the intra-molecular interaction, MLL fragments
would dissociate from each other and be subjected to degradation.
Hence, we propose a model in which intra-molecular interaction
takes place first, followed by Taspase 1-dependent cleavage in the
proper maturation process of MLL (Figure 7E).
Previous analysis of fetal and adult hematopoiesis showed that
MLL is required for sufficient proliferative expansion of hemato-
poietic progenitors [3], [4], [7], [8]. During myeloid differentia-
tion, MLL maintains expression of posterior Hoxa genes [3], [4],
which are highly expressed in HSCs/MPPs and progressively
down-regulated in more differentiated progenitors [12], [27]
(Figure 4A). Posterior Hoxa genes are required to sufficiently
promote proliferation of undifferentiated hematopoietic progeni-
tors [5], [6], [12]. Hence, MLL-dependent HOX gene expression is
necessary to maintain appropriate pool sizes of HSCs and
immature progenitors. Our in vivo analyses of uc homozygous
and de homozygous mutant mice show that intra-molecular
complex formation but not MLL processing is required for proper
expansion of hematopoietic progenitors. MLL fusion proteins
generated by chromosomal translocations constitutively activate
posterior HOXA genes to cause leukemia and therefore those
mutations are defined as gain-of-function. Our analysis of de
homozygous MEFs showed that loss of intra-molecular complex
formation results in degradation of MLL proteins and impaired
expression of MLL target genes. Thus, although deletion of exon
11 was originally found in ALL [21], this mutation is defined as
loss-of-function, suggesting that this mutation likely contributes to
leukemogenesis through different mechanisms from MLL fusion-
dependent leukemogenesis.
MLL fragments generated by proteolytic processing associate
with each other by non-covalent interaction, which potentially
allows conditional dissociation of the MLL holocomplex. In
accord with this hypothesis, genome wide ChIP analysis of
Drosophila embryos showed that trithorax (TRX) protein
fragments generated by processing differentially associate with
the Drosophila genome [31]. Therefore, it was thought that MLLC
might dissociate from MLLN in a context-dependent manner to
become functionally inactive. In this scenario, the unprocessed
mutant protein might function as the constitutively active form.
However, unlike MLL fusion proteins, the uncleavable mutant did
not enhance serial replating activity of hematopoietic progenitors
(Figure 5D), indicating that conditional dissociation of MLLC is
not the major mechanism for extinguishing MLL activity during
myeloid differentiation.
It has been proposed that MLL processing might be important
for maintaining expression of the Antenapedia complex (ANT-C)
genes. This concept was originated by the study of a Drosophila
TRX mutant (trxE3) that contains an internal deletion of amino
acids encompassing the processing site and therefore exclusively
expresses an uncleavable mutant protein [32], [33]. trxE3 exhibits
mildly reduced ANT-C expression in late stages and normal
bithorax complex (BX-C) expression, whereas the TRX null
mutant (trxB11) displays mildly decreased expression of ANT-C
genes in late embryonic development and severely decreased
expression of BX-C genes in early embryonic development. Thus,
it was hypothesized that TRX processing might be required
specifically for late ANT-C expression in fly embryonic develop-
ment. However, our current results show that uc homozygous mice
have no developmental defects. Furthermore, expression of Hoxc4,
which is a member of the ANT-C genes, in uc homozygous MEFs
was comparable to the wild type control (Figure 3F). Expression of
Hoxc8, which is a member of the BX-C genes, was severely
decreased in dC homozygous MEFs, but unaffected in uc
homozygous MEFs. Thus, our results indicate that the role of
MLL processing on HOX gene expression is minor, if any, in
mammalian development.
Taspase 1 knock out mice demonstrate various defects including
smaller body size, reduced MEF proliferation, and skeletal
structural anomalies [25]. More specifically, Taspase 1 deficiency
causes upregulation of CDK inhibitors such as p16 and ARF (the
products of the Cdkn2a gene) to inhibit proliferation of MEFs.
However, uc homozygous mice were born with normal body size,
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and uc homozygous MEFs did not display severely altered
expression of Cdkn2a (Figure 3F) nor manifested severe prolifer-
ation defects (Figure 3G) in contrast to a previous study that also
analyzed mice engineered to express an uncleavable MLL protein
[25]. The basis for these differences between the two indepen-
dently generated mouse lines is unclear since detailed description
of the mice generated by Takeda et al. was not reported [25], but
may be due to differences in genetic backgrounds of the ES cells or
the targeting vector. Nevertheless, our results indicate that MLL
processing does not serve rate-limiting roles for proliferation and
suggest that the growth defects caused by Taspase 1-deficiency
may be attributed to other substrates such as MLL2 [25] or TFIIA
[34].
Taken together, our results indicate that MLL processing has no
biological roles in development, hematopoiesis and proliferation,
whereas intra-molecular interaction of MLL is essential in all of
those circumstances. However, evolutionary conservation of the
processing sites suggests that MLL processing has some biological
roles. It may be important under other circumstances not tested in
this study such as stress conditions and immunity.
Conclusions
In the current study, we examined the in vivo roles of intra-
molecular interaction and proteolytic processing of MLL in
various assays. Loss of intra-molecular interaction caused loss-of-
MLL function, whereas loss of processing caused no detectable
functional alterations. These results unequivocally demonstrate
that formation of an intra-molecular complex is, but the processing
is not, required for MLL-dependent gene activation and cell
proliferation.
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